Registration Dossier
Registration Dossier
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 201-083-8 | CAS number: 78-10-4
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data

Acute Toxicity: inhalation
Administrative data
- Endpoint:
- acute toxicity: inhalation
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Study period:
- 1991/07/19 - 1991/10/16
- Reliability:
- 1 (reliable without restriction)
- Rationale for reliability incl. deficiencies:
- guideline study
Data source
Reference
- Reference Type:
- study report
- Title:
- Unnamed
- Year:
- 1 991
- Report date:
- 1991
Materials and methods
Test guideline
- Qualifier:
- according to guideline
- Guideline:
- OECD Guideline 403 (Acute Inhalation Toxicity)
- GLP compliance:
- yes
- Test type:
- traditional method
- Limit test:
- no
Test material
- Reference substance name:
- Tetraethyl orthosilicate
- EC Number:
- 201-083-8
- EC Name:
- Tetraethyl orthosilicate
- Cas Number:
- 78-10-4
- Molecular formula:
- C8H20O4Si
- IUPAC Name:
- tetraethyl orthosilicate
- Test material form:
- liquid
Constituent 1
Test animals
- Species:
- rat
- Strain:
- other: Wiskf(SPF71)
- Sex:
- male/female
- Details on test animals or test system and environmental conditions:
- TEST ANIMALS
- Source: HOECHST AG, Kastengrund, SPF-Zucht
- Age at study initiation: 8-10 weeks
- Weight at study initiation: Male rats weighed 193-234 g at the time of dosing and female rats weighed 190-202 g at dosing
- Housing: In an airconditioned room in Makrolon type 4 cages, 5 animals per cage
- Diet: Rat diet Altromin 1324, ad libitum
- Water: Tap water, ad libitum
- Acclimation: At least 5 days
ENVIRONMENTAL CONDITIONS
- Temperature (°C): 22 +/- 2
- Humidity (%): 50 +/- 20
- Photoperiod (hrs dark / hrs light): 12/12
Administration / exposure
- Route of administration:
- inhalation: aerosol
- Type of inhalation exposure:
- nose/head only
- Vehicle:
- other: unchanged (no vehicle)
- Details on inhalation exposure:
- GENERATION OF TEST ATMOSPHERE / CHAMBER DESCRIPTION
- Exposure apparatus: The test substance was injected into the chamber at constant velocity through an infusion apparatus at one end of the chamber.
- Exposure chamber volume: 60 L
- Method of holding animals in test chamber: The animals were in a stainless steel and glass cylinder, with plastic tubes leading to the exposure cylinder designed so that the animal's noses fit inside.
- Source and rate of air: The air supply was kept constant at 800 L/h through a calibrated rotameter.
- Method of conditioning air: A suction device at the bottom of the inhalation chamber enabled the air to be passed through, attached to a water bottle, a Buehler filter and a bottle of calcium chloride.
- System of generating particulates/aerosols: The primary aerosol formation took place in the generation flasks, and the smaller particles were passed into the inhalation chamber through a riser pipe.
- Method of particle size determination: Determination of the particle size was only possible at the highest concentration because the test substance was mostly in the gaseous phase as the concentrations decreased.
- Treatment of exhaust air: Exhaust air was extracted and neutralised.
- Temperature, humidity, pressure in air chamber: An air monitoring system (Hartmann & Braun) continuously recorded CO, CO2, O2, humidity and temperature in the exposure chamber.
TEST ATMOSPHERE
- Brief description of analytical method used: For the determination of the test material concentration in the inhalation chamber, 31 L of the test atmosphere during a 60-minute period of the exposure period was analysed by passing it through a series of connected gas wash bottles which were completely filled with 70, 60 and 50 mL absolute ethanol residing in a cold bath. The distribution of aerosol particle size was determined using an Anderson-Cascade Impactor 3 (Anderson Samples Inc, Atlanta). Mean relative abundances of aerodynamic diameter were determined. The device was operated at a vacuum flow rate of 9.5 L/min, from which a flow velocity of 1.25 m/s was calculated.
- Samples taken from breathing zone: Yes
TEST ATMOSPHERE (if not tabulated)
- MMAD (Mass median aerodynamic diameter) / GSD (Geometric st. dev.): 0.8 micrometers / 1.7. - Analytical verification of test atmosphere concentrations:
- yes
- Remarks:
- Gas chromatography using an FID as a detector.
- Duration of exposure:
- 4 h
- Concentrations:
- 5.74, 9.98, 10.40 and 16.83 mg/L
- No. of animals per sex per dose:
- 5M, 5F per dose, except no females in the 5.74 mg/L dose
- Control animals:
- no
- Details on study design:
- - Duration of observation period following administration: 14 days
- Frequency of observations and weighing: Rats were observed for clinical symptoms during the 4-hour exposure period and then twice per day for 14 days post exposure. Body weights were determined prior to dosing and on days 8 and 15 of the study.
- Necropsy of survivors performed: Yes - Statistics:
- The LC50 and 95% confidence limits were calculated according to Fieller and Sidak and probit analysis was carried out on the mortality data according to Finney and Weber.
Results and discussion
Effect levelsopen allclose all
- Sex:
- male
- Dose descriptor:
- LC50
- Effect level:
- 10 mg/L air
- Exp. duration:
- 4 h
- Remarks on result:
- other: aerosol
- Sex:
- female
- Dose descriptor:
- LC50
- Effect level:
- > 16.8 mg/L air
- Exp. duration:
- 4 h
- Remarks on result:
- other: aerosol
- Mortality:
- Deaths first occurred on or just before the 3rd test day. Please see Table 1.
- Clinical signs:
- other: The animals showed reactions involving motor behavior and respiration, palpebral stenosis extending to full lid closure with encrusted blood covered eyelid rims, shivering and tonic cramping. Cyanosis and decreased reflexes occurred in individual animals.
- Body weight:
- Body weights were decreased during the study but by the completion of the study, all the animals exceeded their initial weight.
- Gross pathology:
- Necropsy results from animals which died during the study showed red and orange coloured lungs, release of froth upon incision of the lungs and lung spotting. Spotting or light colouration of the lungs were found in every female rat sacrificed at the end of the study. There were no macroscopic findings in the male rats sacrificed at the end of the study.
Any other information on results incl. tables
Table 1: Concentrations, exposure conditions and mortality per animals treated
Analytical Conc. (mg/L) |
Mortality (# dead/total) |
||
Males |
Females |
Combined |
|
5.74 |
1/5 |
- |
1/5 |
9.98 |
2/5 |
0/5 |
2/10 |
10.40 |
3/5 |
1/5 |
4/10 |
16.83 |
4/5 |
1/5 |
5/10 |
- = Not tested
Value [LC50]: 10.0 mg/L for male rats and >16.8 mg/L for female rats.
Applicant's summary and conclusion
- Interpretation of results:
- GHS criteria not met
- Conclusions:
- In a study conducted according to OECD Test Guideline 403 and GLP compliant (reliability score 1), tetraethyl orthosilicate was determined to have a 4-hour LC50 of 10.0 mg/L aerosol in male rats and >16.8 mg/l aerosol in female rats.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.

EU Privacy Disclaimer
This website uses cookies to ensure you get the best experience on our websites.